18 related articles for article (PubMed ID: 3926809)
1. Bromocriptine modulates the expression of PTHrP receptor, Indian hedgehog, and Runx2 proteins in the growth plate of lactating rats.
Wongdee K; Thonapan N; Saengamnart W; Krishnamra N; Charoenphandhu N
Mol Cell Biochem; 2013 Sep; 381(1-2):191-9. PubMed ID: 23744531
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy in Canada: end of one era and beginning of another.
Dean HJ; Friesen HG
CMAJ; 1986 Aug; 135(4):297-301. PubMed ID: 3089574
[TBL] [Abstract][Full Text] [Related]
3. Clonidine treatment in children with short stature.
Loche S; Lampis A; Cella SG; Locatelli V; Müller EE; Pintor C
J Endocrinol Invest; 1988 Nov; 11(10):763-7. PubMed ID: 3068294
[No Abstract] [Full Text] [Related]
4. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.
Müller EE; Locatelli V; Ghigo E; Cella SG; Loche S; Pintor C; Camanni F
Drugs; 1991 Feb; 41(2):161-77. PubMed ID: 1709847
[TBL] [Abstract][Full Text] [Related]
5. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
6. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
Huseman CA; Hassing JM; Sibilia MG
J Clin Endocrinol Metab; 1986 Mar; 62(3):484-90. PubMed ID: 3080463
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
8. Serum luteinizing hormone and follicle-stimulating hormone and the response to luteinizing hormone-releasing factor in children and adolescents with isolated growth hormone deficiency.
Cohen HN; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1983 Oct; 57(4):855-8. PubMed ID: 6411756
[TBL] [Abstract][Full Text] [Related]
9. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
Lampit M; Hochberg Z
J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
[TBL] [Abstract][Full Text] [Related]
10. Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
Huseman CA
J Clin Endocrinol Metab; 1985 Sep; 61(3):514-9. PubMed ID: 3926809
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
